Literature DB >> 3838990

ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors.

B K Ray, T G Lawson, J C Kramer, M H Cladaras, J A Grifo, R D Abramson, W C Merrick, R E Thach.   

Abstract

Interaction of protein synthesis initiation factors with mRNA has been studied in order to characterize early events in the eukaryotic translation pathway. Individual reovirus mRNAs labeled with 32P in the alpha position relative to the m7G cap and eukaryotic initiation factor (eIF)-4A, -4B, and -4F purified from rabbit reticulocytes were employed. It was found that eIF-4A causes a structural change in mRNA, as evidenced by a nuclease sensitivity test: addition of high concentrations of eIF-4A greatly increase the nuclease sensitivity of the mRNA, suggesting that this factor can melt or "unwind" mRNA structure. ATP is required for this reaction. At low concentrations of eIF-4A, addition of eIF-4B is required for maximal unwinding activity. Thus eIF-4B enhances eIF-4A activity. Addition of eIF-4F also makes the mRNA sensitive to nuclease indicating a similar unwinding role to that of eIF-4A. Stoichiometric comparisons indicate that eIF-4F is more than 20-fold more efficient than eIF-4A in catalyzing this reaction. The unwinding activity of eIF-4F is inhibited by m7GDP, while that of eIF-4A is not. This suggests that eIF-4A functions independent of the 5' cap structure. Our results also suggest that the unwinding activity of eIF-4F is located in the 46,000-dalton polypeptide of this complex, which has shown by others to be similar or identical to eIF-4A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838990

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  136 in total

Review 1.  Programmed cell death during endosperm development.

Authors:  T E Young; D R Gallie
Journal:  Plant Mol Biol       Date:  2000-10       Impact factor: 4.076

2.  Cap-independent translation conferred by the 5' leader of tobacco etch virus is eukaryotic initiation factor 4G dependent.

Authors:  D R Gallie
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure.

Authors:  Y V Svitkin; A Pause; A Haghighat; S Pyronnet; G Witherell; G J Belsham; N Sonenberg
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

4.  Assembly of 48S translation initiation complexes from purified components with mRNAs that have some base pairing within their 5' untranslated regions.

Authors:  Sergei E Dmitriev; Ilya M Terenin; Yan E Dunaevsky; William C Merrick; Ivan N Shatsky
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 5.  Protein-protein interactions required during translation.

Authors:  Daniel R Gallie
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

6.  Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.

Authors:  E E Wyckoff; R E Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 7.  Power of yeast for analysis of eukaryotic translation initiation.

Authors:  Michael Altmann; Patrick Linder
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

8.  Translation initiation factor 4A from Saccharomyces cerevisiae: analysis of residues conserved in the D-E-A-D family of RNA helicases.

Authors:  S R Schmid; P Linder
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

9.  Both the 5' untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro.

Authors:  D Falcone; D W Andrews
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

10.  Separation of protein synthesis initiation factor eIF4A from a p220-associated cap binding complex activity.

Authors:  D Etchison; S Milburn
Journal:  Mol Cell Biochem       Date:  1987-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.